• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS ANTI-SARS-COV2 IGG REAGENT; IN VITRO DIAGNOSTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS ANTI-SARS-COV2 IGG REAGENT; IN VITRO DIAGNOSTICS Back to Search Results
Catalog Number 6199919
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 07/02/2020
Event Type  malfunction  
Manufacturer Narrative
The investigation determined that reproducible, discordant vitros anti- sars-cov-2 igg results were obtained from a single patient sample when processed using vitros cov2igg reagent lot 0120 on a vitros xt7600 integrated system.A definitive assignable cause for the discordant reactive results could not be determined with the information provided.Based on historical quality control results, a vitros cov2igg reagent performance issue is not a likely contributor to the event as all qc fluid results were within the correct ifu interpretation region.Additionally, there is also no indication of any instrument malfunction and unexpected instrument performance is not a likely contributor to the event.However, it cannot be entirely ruled out as a contributing factor as precision testing to assess instrument performance was not performed by the customer when requested.In addition, it was not possible to establish if the customer is following the sample collection device manufacturer¿s recommended centrifugation protocol; therefore, pre-analytical sample processing cannot be ruled out as a contributing factor.It is possible that cellular debris, due to poor sample preparation, was present in the affected samples, although this could not be confirmed.The patient that produced the discordant vitros results had not previously tested positive for covid-19 infection and was not known to have an active covid-19 infection at the time of testing.The most likely cause of the discordant results in this case is the vitros cov2igg test generated false positive results for the sample under test.The vitros cov2igg ifu does not preclude the possibility of false positive cov2igg results due to cross-reactivity from pre-existing antibodies or other possible causes.Continual tracking and trending of complaints has not identified any signals that would point to a potential systemic issue with vitros cov2igg lot 0120.
 
Event Description
An ortho clinical diagnostics (ortho) laboratory specialist (ls) contacted the ortho technical solutions centre (tsc) on behalf of a customer to report a discordant reactive vitros anti- sars-cov-2 igg (cov2igg) result obtained from a single patient sample on a vitros xt7600 integrated system.The vitros cov2igg result was considered discordant as non-reactive result was obtained for the same sample tested using a vitros anti- sars-cov-2 total (cov2tot) method.Patient 1 result of 3.11, 3.13 and 3.63 s/c (reactive) versus the expected result of non-reactive.Biased results of the magnitude and direction observed may lead to inappropriate physician action if they were to occur undetected on patient samples.The vitros cov2igg results were not reported from the laboratory to a physician and were not used to aid in the diagnosis of sars-cov-2 infection.Patient management was not influenced based on the vitros results and there was no allegation of patient harm as a result of this event.This report is number 1 of 2 mdr¿s for this event.Two (2) 3500a forms are being submitted for this event as 2 devices were involved.This report corresponds to ortho clinical diagnostics inc.Complaint numbers (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITROS IMMUNODIAGNOSTIC PRODUCTS ANTI-SARS-COV2 IGG REAGENT
Type of Device
IN VITRO DIAGNOSTICS
Manufacturer (Section D)
ORTHO-CLINICAL DIAGNOSTICS
100 indigo creek drive
rochester NY 14626
Manufacturer (Section G)
ORTHO CLINICAL DIAGNOSTICS
felindre meadows
pencoed
bridgend, wales CF35 5PZ
UK   CF35 5PZ
Manufacturer Contact
james a stevens
1001 route 202
raritan, NJ 08869
9082188223
MDR Report Key10312005
MDR Text Key201102285
Report Number3007111389-2020-00078
Device Sequence Number1
Product Code QKO
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other
Type of Report Initial
Report Date 07/22/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/22/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/09/2020
Device Catalogue Number6199919
Device Lot Number0120
Was Device Available for Evaluation? Yes
Date Manufacturer Received07/02/2020
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/12/2020
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-